The human papilloma virus (HPV) vaccination recommendations and funded programs for adults: A targeted literature review

Abstract

HPV vaccination in adults provides opportunities for individuals who were previously ineligible, or who missed vaccination as adolescents, thereby reducing HPV-related disease burden. This targeted literature review summarizes the HPV vaccination recommendations and guidelines by National Immunization Technical Advisory Groups and professional societies, and public funded programs for adults. Of the 152 jurisdictions examined, 62 offered HPV vaccination recommendations for general adults. Of these, 84% included both genders and 68% included sub-populations. Four jurisdictions had recommendations for adult sub-populations only. Overall, 38 jurisdictions had funded programs for general adults and 17 targeted specific sub-populations. The most reported upper eligible age for recommendations or guidelineswas 26 y and 45 y, and 26 y for funded programs. People with HIV and immunosuppressed individuals were the most common sub-populations included. While economic reasons may influence funding for HPV vaccination among adults, clinical guidelines are more likely to advise vaccination on an individual basis, regardless of age.